Substituted Heterocycles as Therapeutic agents for treating cancer
WO2011106650A2
Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
DE102008031036A1
Use of 4-aminothiazolpyrimidine derivatives for the treatment of associated organ transplants
DE102008031038A1
Use of 2-indolinone derivatives for the treatment of organ transplantation
DE102008031040A1
Use of 2-aminopyrimidine derivatives for the treatment of organ transplantation
DE102008031035A1
Use of urea derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations
DE102008031039A1
Use of N-phenylquinazolin-4-amine derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations
DE102008031037A1
Use of 2-aminopyrimidine derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations
US2008280769A1
Selective and dual-action p53/MDM2/MDM4 antagonists
DE102008015250A1
New drugs synthesis
DE102007013812A1
New 1-azacycloalkylimidazole derivatives useful for treating cancer, malaria, cardiovascular diseases or Alzheimer's disease
DE102005020882A1
Use of gaboxadol and its derivatives as kinase inhibitor for the treatment of e.g. kinase induced disease, cancer, age-related macular degeneration, diabetic retinopathy and angiogenesis
DE102004030227A1
Treatment of diseases (e.g. proliferative diseases of tumor cells, ophthalmic diseases and skin diseases) associated with angiogenesis comprises administration of carbamide compounds
